1. Home
  2. CYRX vs DSM Comparison

CYRX vs DSM Comparison

Compare CYRX & DSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CYRX
  • DSM
  • Stock Information
  • Founded
  • CYRX 1999
  • DSM 1989
  • Country
  • CYRX United States
  • DSM United States
  • Employees
  • CYRX N/A
  • DSM N/A
  • Industry
  • CYRX Biotechnology: Pharmaceutical Preparations
  • DSM Investment Managers
  • Sector
  • CYRX Health Care
  • DSM Finance
  • Exchange
  • CYRX Nasdaq
  • DSM Nasdaq
  • Market Cap
  • CYRX 310.4M
  • DSM 289.7M
  • IPO Year
  • CYRX N/A
  • DSM N/A
  • Fundamental
  • Price
  • CYRX $6.09
  • DSM $5.85
  • Analyst Decision
  • CYRX Strong Buy
  • DSM
  • Analyst Count
  • CYRX 6
  • DSM 0
  • Target Price
  • CYRX $11.50
  • DSM N/A
  • AVG Volume (30 Days)
  • CYRX 663.5K
  • DSM 161.7K
  • Earning Date
  • CYRX 05-06-2025
  • DSM 01-01-0001
  • Dividend Yield
  • CYRX N/A
  • DSM 3.97%
  • EPS Growth
  • CYRX N/A
  • DSM N/A
  • EPS
  • CYRX N/A
  • DSM N/A
  • Revenue
  • CYRX $228,385,000.00
  • DSM N/A
  • Revenue This Year
  • CYRX $9.18
  • DSM N/A
  • Revenue Next Year
  • CYRX $8.65
  • DSM N/A
  • P/E Ratio
  • CYRX N/A
  • DSM N/A
  • Revenue Growth
  • CYRX N/A
  • DSM N/A
  • 52 Week Low
  • CYRX $4.58
  • DSM $4.69
  • 52 Week High
  • CYRX $20.11
  • DSM $6.05
  • Technical
  • Relative Strength Index (RSI)
  • CYRX 47.99
  • DSM 47.72
  • Support Level
  • CYRX $5.90
  • DSM $5.75
  • Resistance Level
  • CYRX $7.00
  • DSM $6.10
  • Average True Range (ATR)
  • CYRX 0.61
  • DSM 0.05
  • MACD
  • CYRX 0.03
  • DSM -0.01
  • Stochastic Oscillator
  • CYRX 35.88
  • DSM 52.78

About CYRX CryoPort Inc.

CryoPort Inc is a leader serving the life sciences industry as a provider of integrated temperature-controlled supply chain solutions supporting the life sciences in the biopharma/pharma, animal health, and reproductive medicine markets. It operates in two reportable segments: Life Sciences Services and Life Sciences Products. Geographically the company operates in the Americas, Europe, the Middle East and Africa (EMEA), and Asia Pacific (APAC), generating a majority of its revenue from the Americas.

About DSM BNY Mellon Strategic Municipal Bond Fund Inc.

BNY Mellon Strategic Municipal Bond Fund, Inc. is a diversified closed-end management investment company. Its investment objective is to seek to maximize current income exempt from federal income tax to the extent consistent with the preservation of capital.

Share on Social Networks: